![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SJ Grossman and DJ Jollow
Department of Pharmacology, Medical University of South Carolina, Charleston.
The hemolytic anemia which frequently accompanies treatment of individuals with dapsone and other arylamine drugs is believed to be caused not by the parent drugs per se, but rather by metabolites which are formed during the clearance of the drugs in vivo. To determine whether the N-hydroxyarylamine metabolites of dapsone could be responsible for dapsone-induced hemolysis, dapsone, dapsone hydroxylamine (DDS-NOH) and monoacetyldapsone hydroxylamine were administered to rats which had previously received 51Cr-labeled red blood cells. All three compounds caused an increase in the rate of disappearance of radioactivity from the blood as compared with saline- treated controls. In parallel in vitro studies, incubation of 51Cr- labeled red blood cells with DDS-NOH, but not dapsone or monoacetyldapsone, induced a decrease in survival time of the radiolabeled cells when they were reintroduced into isologous rats. The disappearance of radioactivity from the blood was matched by its selective uptake into the spleen. The amount of damage (as measured by decreased red cell survival in vivo) was proportional to both concentration and time of exposure to DDS-NOH. The area under the blood concentration vs. time curve for total arylhydroxylamines (DDS-NOH + monacetyldapsone hydroxylamine) in rats given a hemotoxic dose of dapsone was similar to that of rats given an equitoxic dose of DDS-NOH. Collectively, these data indicate that the hydroxylamine metabolites of dapsone are direct acting hemolytic agents that are formed from dapsone in sufficient amounts to account for their being the sole mediators of dapsone-induced hemolytic anemia in the rat.
This article has been cited by other articles:
|
|
 |
|
  D. C. McMillan, C. L. Powell, Z. S. Bowman, J. D. Morrow, and D. J. Jollow Lipids versus Proteins as Major Targets of Pro-Oxidant, Direct-Acting Hemolytic Agents Toxicol. Sci., November 1, 2005; 88(1): 274 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. C. Bolchoz, A. K. Gelasco, D. J. Jollow, and D. C. McMillan Primaquine-Induced Hemolytic Anemia: Formation of Free Radicals in Rat Erythrocytes Exposed to 6-Methoxy-8-hydroxylaminoquinoline J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1121 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. C. Bolchoz, J. D. Morrow, D. J. Jollow, and D. C. McMillan Primaquine-Induced Hemolytic Anemia: Effect of 6-Methoxy-8-hydroxylaminoquinoline on Rat Erythrocyte Sulfhydryl Status, Membrane Lipids, Cytoskeletal Proteins, and Morphology J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 141 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. C. Bolchoz, R. A. Budinsky, D. C. McMillan, and D. J. Jollow Primaquine-Induced Hemolytic Anemia: Formation and Hemotoxicity of the Arylhydroxylamine Metabolite 6-Methoxy-8-hydroxylaminoquinoline J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 509 - 515. [Abstract] [Full Text]
|
|
|
|
|
|
T. P. Reilly, P. M. Woster, and C. K. Svensson Methemoglobin Formation by Hydroxylamine Metabolites of Sulfamethoxazole and Dapsone: Implications for Differences in Adverse Drug Reactions J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 951 - 959. [Abstract] [Full Text]
|
|
|
|
|
|
D. C. McMillan, C. B. Jensen, and D. J. Jollow Role of Lipid Peroxidation in Dapsone-Induced Hemolytic Anemia J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 868 - 876. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Rossi, D. Barra, A. Bellelli, G. Boumis, S. Canofeni, P. Di Simplicio, L. Lusini, S. Pascarella, and G. Amiconi Fast-reacting Thiols in Rat Hemoglobins Can Intercept Damaging Species in Erythrocytes More Efficiently Than Glutathione J. Biol. Chem., July 24, 1998; 273(30): 19198 - 19206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Tingle, R. Mahmud, J. L. Maggs, M. Pirmohamed, and B. K. Park Comparison of the Metabolism and Toxicity of Dapsone in Rat, Mouse and Man J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 817 - 823. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. H. Hinderling Red Blood Cells: A Neglected Compartment in Pharmacokinetics and Pharmacodynamics Pharmacol. Rev., September 1, 1997; 49(3): 279 - 295. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
